Gabbi raises US$4.4m to advance breast cancer early detection
Gabbi will launch in 2023, giving women access to risk assessment results and personalised care plans
Gabbi will launch in 2023, giving women access to risk assessment results and personalised care plans
By Dr Irem Tezer Ates, Medical Science Director at NuroKor Bioelectronics
The new fund has already made its first close of €12.5 million to date
The nation’s largest partnership of fertility practices aims to push boundaries in science, technology, and innovation
More than three million women in the US suffer from the condition with the rate of diagnosis growing due to the ageing population
The company had to find new ways to deliver critical abortion services following the court ruling
The company's software integrates patient education and engagement into existing clinical workflows to reduce clinical burden
Each year about 264,000 cases of women in the US are diagnosed with breast cancer
A US venture firm focusing on early-stage women’s health start-ups [...]
The Department of Health and Human Services will grant the funding to Rowan University School of Osteopathic Medicine